Both hormones also regulate food intake, and the success of GLP1R agonists and dual GLP1R/GIPR agonists in the treatment of obesity has kindled ongoing research to better understand which target cells are most relevant for these pharmacological outcomes. The gene discussed is GIPR; the disease is Obesity.